Radiation blitz could extend life for lung cancer patients when drugs start failing
NCT ID NCT06813664
Summary
This study is testing whether using precise, high-dose radiation on a few spots where cancer is growing can help patients with advanced lung cancer stay on their current targeted drug therapy longer. It will involve 60 adults whose cancer has specific genetic changes and has started to progress in up to five areas. Researchers will track how long the treatment keeps the cancer from worsening and monitor side effects and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network
Toronto, Ontario, M5G 2M9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.